IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.635
EU - Europa 11.487
AS - Asia 10.064
SA - Sud America 1.794
AF - Africa 228
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 21
Totale 46.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.347
PL - Polonia 3.946
CN - Cina 3.795
SG - Singapore 3.083
UA - Ucraina 2.107
BR - Brasile 1.508
DE - Germania 1.462
HK - Hong Kong 1.213
IT - Italia 1.110
FI - Finlandia 660
VN - Vietnam 605
GB - Regno Unito 599
RU - Federazione Russa 410
TR - Turchia 386
IE - Irlanda 370
IN - India 328
FR - Francia 221
CA - Canada 142
BD - Bangladesh 133
SE - Svezia 115
CZ - Repubblica Ceca 101
ES - Italia 98
ZA - Sudafrica 96
AR - Argentina 95
ID - Indonesia 91
MX - Messico 86
NL - Olanda 77
JP - Giappone 76
EC - Ecuador 58
IQ - Iraq 48
PK - Pakistan 43
IR - Iran 42
AT - Austria 41
BE - Belgio 41
MA - Marocco 39
CO - Colombia 37
VE - Venezuela 31
SA - Arabia Saudita 25
KE - Kenya 23
AU - Australia 22
CL - Cile 22
EU - Europa 19
LT - Lituania 19
MU - Mauritius 19
PE - Perù 19
CH - Svizzera 18
IL - Israele 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 16
JM - Giamaica 16
KZ - Kazakistan 14
PY - Paraguay 14
JO - Giordania 13
KR - Corea 13
PA - Panama 13
PH - Filippine 13
EG - Egitto 12
TH - Thailandia 12
TN - Tunisia 11
RO - Romania 10
DZ - Algeria 9
BG - Bulgaria 8
KG - Kirghizistan 8
LK - Sri Lanka 8
LV - Lettonia 8
CU - Cuba 7
DK - Danimarca 7
ET - Etiopia 7
LB - Libano 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
GE - Georgia 6
GR - Grecia 6
MY - Malesia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AL - Albania 5
HR - Croazia 5
HU - Ungheria 5
NO - Norvegia 5
SN - Senegal 5
BY - Bielorussia 4
EE - Estonia 4
UY - Uruguay 4
BH - Bahrain 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GD - Grenada 2
HN - Honduras 2
IS - Islanda 2
LU - Lussemburgo 2
SV - El Salvador 2
Totale 46.234
Salva come PNG Salva come JPEG
Città #
Warsaw 3.936
Fairfield 3.026
Woodbridge 2.187
Ashburn 1.980
Jacksonville 1.580
Houston 1.506
Singapore 1.431
Hong Kong 1.201
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.098
Wilmington 1.062
Beijing 880
Chandler 798
Princeton 669
Nanjing 581
New York 469
Los Angeles 403
Brescia 381
Dublin 366
Dearborn 337
Dallas 323
Helsinki 308
Istanbul 302
The Dalles 241
Munich 221
Dong Ket 181
Nanchang 180
Ho Chi Minh City 170
San Francisco 161
Buffalo 160
Moscow 160
Shenyang 151
Des Moines 149
São Paulo 149
Hebei 144
Jinan 142
Changsha 138
San Diego 132
Shanghai 126
Milan 123
Chicago 111
Lancaster 104
Tianjin 102
Jiaxing 101
Redondo Beach 96
Santa Clara 91
London 90
Hanoi 88
Boardman 77
Kunming 73
Tokyo 71
Turku 69
Brooklyn 66
Phoenix 66
Brno 64
Jakarta 64
Hangzhou 63
San Mateo 61
Madrid 54
Verona 53
Guangzhou 51
Johannesburg 50
Haikou 48
Toronto 47
Rome 45
Zhengzhou 44
Augusta 43
Ningbo 43
Lanzhou 42
Rio de Janeiro 42
Boston 41
Stockholm 40
Orem 39
Nuremberg 38
Chennai 36
Belo Horizonte 35
Brussels 35
Denver 35
Kocaeli 35
Montreal 34
Leawood 33
Washington 33
Porto Alegre 32
Charlotte 31
Poplar 31
Amsterdam 29
Fuzhou 29
Taizhou 28
Atlanta 27
Mexico City 27
Changchun 26
Olomouc 26
Curitiba 25
Dhaka 25
Hefei 25
Kilburn 25
Ardabil 24
Brasília 24
Norwalk 24
Totale 32.815
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 322
The nanostructured secretome 318
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 316
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 303
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 299
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 297
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 289
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 283
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 281
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 275
Claudin3 is localized outside the tight junctions in human carcinomas 272
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 270
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 268
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 265
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 263
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 263
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 262
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 261
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 259
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 258
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 258
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 256
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 251
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 251
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 250
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 249
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 248
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 245
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 241
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 240
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 239
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 237
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 233
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 232
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 230
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 222
Zebrafish disease models in hematology: Highlights on biological and translational impact 215
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 210
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 208
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 205
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 202
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 201
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 197
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 197
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 197
Long pentraxin-3 follows and modulates bladder cancer progression 196
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 195
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 194
Anti-angiogenic activity of the purine analog 6-thioguanine. 194
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 193
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 192
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 191
The zebrafish/tumor xenograft angiogenesis assay. 190
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 188
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 187
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 186
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 184
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 183
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 182
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 181
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 179
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 179
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 179
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 176
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 173
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 173
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 173
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 172
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 170
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 169
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 169
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 169
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 168
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 167
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 167
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 165
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 165
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 164
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 163
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 163
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 162
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 161
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 161
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 161
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 160
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 160
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 159
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 158
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 158
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 158
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 157
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 157
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 156
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 155
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 155
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 155
Beta-Galactosylceramidase deficiency: neurovascular implications 154
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 154
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 154
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 153
Totale 20.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 205.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.934 0 0 0 0 0 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/20267.463 1.327 1.675 1.078 1.838 1.441 104 0 0 0 0 0 0
Totale 47.005